A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel highlighted various alleged “safety uncertainties” of the mRNA COVID-19 ...
Restoring P53's autonomous anti-cancer function through P53 mRNA delivery is a promising anti-tumor strategy. Yet, in tumors harboring mutant P53, the existing mutant P53 (Mutp53) would interferes ...
MHH project wins start-up funding competition organised by Lower Saxony research incubator Institute for Biomedical Translation Lower Saxony.
RCT2100 co-administered with ivacaftor will assess the safety and tolerability of inhaled CFTR mRNA therapy over 6 weeks in participants with CF - - U.S. sites now enrolling, with U.K. and EU ...
A bowlful of papaya for breakfast can do wonders for your body. Wondering why? Well, because even Ayurveda calls it a healing fruit that balances the body and supports Agni, or digestive fire. When ...
Clinical Trials Arena on MSN
ReCode initiates Phase II trial of RCT2100 with ivacaftor for CF
The open-label, multi-part Phase II trial will assess RCT2100’s biodistribution, safety, and tolerability via oral inhalation ...
News Medical on MSN
Development of therapeutic cancer vaccines based on cancer immunity cycle
Therapeutic cancer vaccines have experienced a remarkable resurgence over the past decade, representing a paradigm shift in ...
Hundreds Of Genes Act Differently In The Brains Of Men And Women. Differences between men and women in intelligence and behaviour have been proposed and disputed for decades.Now, a growing body of sci ...
A peek inside some leading research labs shows how scientists-turned-detectives are painstakingly decoding what causes ...
This important study describes a deep learning framework that analyzes single-cell RNA data to identify a tumor-agnostic gene signature associated with brain metastases. The identified signature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results